CoChat
Sign Up
Cited by 129Cardiac electrophysiology and arrhythmiasCardiac Ischemia and ReperfusionCardiovascular Function and Risk Factors

Human SERCA2a levels correlate inversely with age in senescent human myocardium

Open access
Cain, Brian S, Meldrum, Daniel R, Joo, Kyung S, Wang, Ju-Feng, Meng, Xianzhong, Cleveland, Joseph C, Banerjee, Anirban, Harken, Alden H·1998·Journal of the American College of Cardiology
DOI 10.1016/s0735-1097(98)00233-2
Open this paper in CoChat — free accountOpen PDF

Abstract

Objectives This study sought to characterize functional impairment after simulated ischemia-reperfusion (I/R) or Ca2+ bolus in senescent human myocardium and to determine if age-related alterations in myocardial concentrations of SERCA2a, phospholamban, or calsequestrin participate in senescent myocardial dysfunction.Background Candidates for elective cardiac interventions are aging, and an association between age and impairment of relaxation has been reported in experimental animals. Function of the sarcoplasmic reticulum resulting in diastolic dysfunction could be dysregulated at the level of cytosolic Ca2+ uptake by SERCA2a, its inhibitory subunit (phospholamban), or at the level of Ca2+ binding by calsequestrin.Methods Human atrial trabeculae from 17 patients (45-75 years old) were suspended in organ baths, field simulated at 1 Hz, and force development was recorded during I/R (45/120 min). Trabeculae from an additional 12 patients (53-73 years old) were exposed to Ca2+ bolus (2-3 mmol/L bath concentration). Maximum +/- dF/dt and the time constant of force decay (tau) were measured before and after I/R or Ca2+ bolus and related to age. SERCA2a, phospholamban, and calsequestrin from 12 patients (39-77 years old) were assessed by immunoblot.Results Functional results indicated that maximum +/-dF/dt and tau were prolonged in senescent (>60 years) human myocardium after I/R (p < 0.05). Calcium bolus increased the maximum +/-dF/dt and decreased tau in younger, but not older patients (p < 0.05). SERCA2a and the ratio of SERCA2a to either phospholamban or calsequestrin were decreased in senescent human myocardium (p < 0.05).Conclusions Senescent human myocardium exhibits decreased myocardial SERCA2a content with age, which may, in part, explain impaired myocardial function after either I/R or Ca2+ exposure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(98)00233-2

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SERCA2a protein levels were found to be significantly decreased in senescent human myocardium that is characterized by HFpEF, which was associated with myocardial function impairment at baseline that was exacerbated by hypoxic conditions and higher heart rates.

    “Furthermore, SERCA2a protein levels were found to be significantly decreased in senescent human myocardium that is characterized by HFpEF, 50 which was associated with myocardial function impairment at baseline that was exacerbated by hypoxic conditions and higher heart rates.[51][52][53]”

    From Reversal of contractile defects by mediating calcium homeostasis in human mini-heart models of heart failure with preserved ejection fraction (HFpEF) leads to first-in-human gene therapy clinical trial (2024) · cites this paper as [50]

    Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 77 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. Cain BS, Harken AH: Surgical treatment of diastolic dysfunction. J Cardio- vasc Surg 1998;In Press.
  2. Cleveland JC, Meldrum DR, Rowland RT, et al. Ischemic preconditioning in human atrial trabeculae involves alpha 1 adrenoceptors and protein kinase C. Am J Physiol 1997;273:H902-8.
  3. Melchoir T, Gadsboll N, Hildebrandt P, Kober L, Torp-Petersen C. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving and acute myocardial infarction. Diabet Med 1996;13:450 -6.
  4. Kim HW, Steenaart NAE, Furguson DG, Kranias EG. Functional reconsti- tution of the cardiac sarcoplasmic reticulum Ca 2ϩ -ATPase with phospho- lamban in phospholipid vesicles. J Biol Chem 1990;265:1702-9.

Cited by

Sorted by citations

Related

Authors
Cain, B. S., Meldrum, D. R., Joo, K. S., Wang, J.-F., Meng, X., Cleveland, J. C., Banerjee, A., & Harken, A. H.
Corresponding author
Cain, Brian S
ORCID
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
1998-08
Volume
32
Issue
2
Pages
458-467
ISSN
0735-1097 (ISSN-L)
DOI
10.1016/s0735-1097(98)00233-2
OpenAlex
W2032602706
Cited by
129
References
77
Citations by year
2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 4
FWCI
3.54
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r29hl043696-03, 5r01hl044186-04)
  • National Heart, Lung, and Blood Institute (HL-44186, HL 43696)
  • National Institute of General Medical Sciences (GM 08315, T32GM008315)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
SERCA2a, cardiac aging, sarcoplasmic reticulum, phospholamban, calsequestrin, ischemia-reperfusion injury, diastolic dysfunction, calcium uptake
MeSH terms
Phospholamban, Calcium-Transporting ATPases, Adult, Aged, Aging, Analysis of Variance, Calcium, Calcium-Binding Proteins, Calsequestrin, Cytosol, Diastole, Dose-Response Relationship, Drug, Female, Heart Atria, Humans, Male, Middle Aged, Myocardial Contraction, Myocardium, Sarcoplasmic Reticulum, Blotting, Western, Cohort Studies, Myocardial Reperfusion, Linear Models, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review